Apeloa Pharmaceutical Co.,Ltd (SHE: 000739)

Market Cap	18.91B
Revenue (ttm)	12.26B
Net Income (ttm)	1.07B
Shares Out	1.16B
EPS (ttm)	0.92
PE Ratio	17.72
Forward PE	16.51
Dividend	0.32 (1.90%)
Ex-Dividend Date	May 23, 2024

Volume	10,731,247
Open	17.10
Previous Close	16.66
Day's Range	16.27 - 17.10
52-Week Range	10.66 - 18.96
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2024

About Apeloa Pharmaceutical Co.,Ltd

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,208
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2023, Apeloa Pharmaceutical Co.,Ltd's revenue was 11.47 billion, an increase of 8.81% compared to the previous year's 10.54 billion. Earnings were 1.06 billion, an increase of 6.69%.